When the Mother has ADHD: Challenges for Treating Multiplex ADHD in Families
Dr. Mark Stein is Professor of Psychiatry and Behavioral Sciences at Seattle Children's Hospital and principal investigator in the Center for Child, Health, Behavior and Development. His research interests focus on individuals with ADHD and related neurodevelopmental disorders. His work is multidisciplinary in nature, involving genetics, pharmacological treatment and comparative efficacy, pharmacogenemics and sleep of these populations. His latest study tackles an intriguing question: Can you improve how kids at risk for ADHD function by treating their mothers first, either with medicine or parent training?
Friday, November 4, 2016
9:00 am – 10:30 am ESTAdd to Cal
Child Mind Institute
445 Park Avenue
New York, New York
CME Accreditation: This live activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of Northwell Health and Child Mind Institute. Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: Northwell Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy: Northwell Health adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by Northwell Health for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
Planner and Speaker’s Disclosures: Drs. Koplewicz, Steingard and Young have nothing to disclose. Dr. Stein discloses the following: Pfizer provides research support for his role as investigator initiated study; Alcobra provides honorarium for his role on the advisory board; Shire provides research support and honorarium for his role as investigator initiated study and advisory board.
Recognition of Program Support: There is no commercial support for this program.